Cargando…

Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease

AIMS: Recent studies suggested that both left ventricular ejection fraction (LVEF) lower than 60% or higher than 65% were associated with an increased mortality in the general population. Uncertainty remains regarding adverse outcomes across LVEF in coronary artery disease (CAD). The common understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yupeng, Song, Jingjing, Wang, Wenyao, Zhang, Kuo, Qi, Yu, Yang, Jie, Wen, Jun, Meng, Xiangbin, Gao, Jun, Shao, Chunli, Tang, Yi‐Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715855/
https://www.ncbi.nlm.nih.gov/pubmed/35866195
http://dx.doi.org/10.1002/ehf2.14063
_version_ 1784842550312435712
author Liu, Yupeng
Song, Jingjing
Wang, Wenyao
Zhang, Kuo
Qi, Yu
Yang, Jie
Wen, Jun
Meng, Xiangbin
Gao, Jun
Shao, Chunli
Tang, Yi‐Da
author_facet Liu, Yupeng
Song, Jingjing
Wang, Wenyao
Zhang, Kuo
Qi, Yu
Yang, Jie
Wen, Jun
Meng, Xiangbin
Gao, Jun
Shao, Chunli
Tang, Yi‐Da
author_sort Liu, Yupeng
collection PubMed
description AIMS: Recent studies suggested that both left ventricular ejection fraction (LVEF) lower than 60% or higher than 65% were associated with an increased mortality in the general population. Uncertainty remains regarding adverse outcomes across LVEF in coronary artery disease (CAD). The common understanding was that LVEF <40% was associated with an increased risk of mortality. But the threshold at LVEF of 40% was arbitrary because quite a lot of adverse outcomes existed in patients with ejection fraction >40%. We aimed to evaluate the relationship between LVEF and mortality or adverse events in CAD patients undergoing percutaneous coronary intervention (PCI). METHODS AND RESULTS: A total of 10 252 CAD patients undergoing PCI from an observational cohort were studied. All‐cause mortality and major adverse cardiovascular and cerebrovascular events (MACCE) were set as outcomes. Kaplan–Meier curves, adjusted Cox regression models, and restricted cubic spline analyses were used for evaluation. A total of 137 (1.3%) patients had all‐cause mortality, and 816 (8.0%) patients had MACCE during a median of 2.4 years of follow‐up. The median LVEF was 64%. All‐cause mortality and MACCE rates changed substantially across LVEF categories, and a linear inverse relationship of LVEF with all‐cause mortality and MACCE risk was observed. All‐cause mortality or MACCE risk increased significantly below an LVEF of 55 or 65%, respectively. Patients with LVEF <55% had a more than 3.5‐fold higher mortality than those with LVEF ≥55%. Patients with LVEF <65% had a more than 1.3‐fold higher MACCE than those with LVEF ≥65%. Below 55 or 65%, there was a rise in mortality or MACCE. A gradient–response relationship was observed, with an all‐cause mortality risk range between 8.6‐fold and 3.0‐fold increase from LVEF <40 to 50–54.9% and MACCE risk range between 2.4‐fold and 1.4‐fold from LVEF <40 to 60–64.9%. CONCLUSIONS: In CAD patients undergoing PCI, LVEF lower than 55% or LVEF lower than 65% was correlated with increased all‐cause mortality and MACCE respectively, whereas higher LVEF was not.
format Online
Article
Text
id pubmed-9715855
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97158552022-12-05 Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease Liu, Yupeng Song, Jingjing Wang, Wenyao Zhang, Kuo Qi, Yu Yang, Jie Wen, Jun Meng, Xiangbin Gao, Jun Shao, Chunli Tang, Yi‐Da ESC Heart Fail Original Articles AIMS: Recent studies suggested that both left ventricular ejection fraction (LVEF) lower than 60% or higher than 65% were associated with an increased mortality in the general population. Uncertainty remains regarding adverse outcomes across LVEF in coronary artery disease (CAD). The common understanding was that LVEF <40% was associated with an increased risk of mortality. But the threshold at LVEF of 40% was arbitrary because quite a lot of adverse outcomes existed in patients with ejection fraction >40%. We aimed to evaluate the relationship between LVEF and mortality or adverse events in CAD patients undergoing percutaneous coronary intervention (PCI). METHODS AND RESULTS: A total of 10 252 CAD patients undergoing PCI from an observational cohort were studied. All‐cause mortality and major adverse cardiovascular and cerebrovascular events (MACCE) were set as outcomes. Kaplan–Meier curves, adjusted Cox regression models, and restricted cubic spline analyses were used for evaluation. A total of 137 (1.3%) patients had all‐cause mortality, and 816 (8.0%) patients had MACCE during a median of 2.4 years of follow‐up. The median LVEF was 64%. All‐cause mortality and MACCE rates changed substantially across LVEF categories, and a linear inverse relationship of LVEF with all‐cause mortality and MACCE risk was observed. All‐cause mortality or MACCE risk increased significantly below an LVEF of 55 or 65%, respectively. Patients with LVEF <55% had a more than 3.5‐fold higher mortality than those with LVEF ≥55%. Patients with LVEF <65% had a more than 1.3‐fold higher MACCE than those with LVEF ≥65%. Below 55 or 65%, there was a rise in mortality or MACCE. A gradient–response relationship was observed, with an all‐cause mortality risk range between 8.6‐fold and 3.0‐fold increase from LVEF <40 to 50–54.9% and MACCE risk range between 2.4‐fold and 1.4‐fold from LVEF <40 to 60–64.9%. CONCLUSIONS: In CAD patients undergoing PCI, LVEF lower than 55% or LVEF lower than 65% was correlated with increased all‐cause mortality and MACCE respectively, whereas higher LVEF was not. John Wiley and Sons Inc. 2022-07-21 /pmc/articles/PMC9715855/ /pubmed/35866195 http://dx.doi.org/10.1002/ehf2.14063 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Liu, Yupeng
Song, Jingjing
Wang, Wenyao
Zhang, Kuo
Qi, Yu
Yang, Jie
Wen, Jun
Meng, Xiangbin
Gao, Jun
Shao, Chunli
Tang, Yi‐Da
Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
title Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
title_full Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
title_fullStr Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
title_full_unstemmed Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
title_short Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
title_sort association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715855/
https://www.ncbi.nlm.nih.gov/pubmed/35866195
http://dx.doi.org/10.1002/ehf2.14063
work_keys_str_mv AT liuyupeng associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT songjingjing associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT wangwenyao associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT zhangkuo associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT qiyu associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT yangjie associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT wenjun associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT mengxiangbin associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT gaojun associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT shaochunli associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease
AT tangyida associationofejectionfractionwithmortalityandcardiovasculareventsinpatientswithcoronaryarterydisease